Author
Listed:
- William Schachterle
(Ansary Stem Cell Institute, Weill Cornell Medicine)
- Chaitanya R. Badwe
(Ansary Stem Cell Institute, Weill Cornell Medicine)
- Brisa Palikuqi
(Ansary Stem Cell Institute, Weill Cornell Medicine)
- Balvir Kunar
(Ansary Stem Cell Institute, Weill Cornell Medicine)
- Michael Ginsberg
(Angiocrine Bioscience)
- Raphael Lis
(Ansary Stem Cell Institute, Weill Cornell Medicine)
- Masataka Yokoyama
(Ansary Stem Cell Institute, Weill Cornell Medicine)
- Olivier Elemento
(HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College)
- Joseph M. Scandura
(Ansary Stem Cell Institute, Weill Cornell Medicine
Hematology-Oncology, Weill Cornell Medical College and the New York Presbyterian Hospital)
- Shahin Rafii
(Ansary Stem Cell Institute, Weill Cornell Medicine)
Abstract
Transplanting vascular endothelial cells (ECs) to support metabolism and express regenerative paracrine factors is a strategy to treat vasculopathies and to promote tissue regeneration. However, transplantation strategies have been challenging to develop, because ECs are difficult to culture and little is known about how to direct them to stably integrate into vasculature. Here we show that only amniotic cells could convert to cells that maintain EC gene expression. Even so, these converted cells perform sub-optimally in transplantation studies. Constitutive Akt signalling increases expression of EC morphogenesis genes, including Sox17, shifts the genomic targeting of Fli1 to favour nearby Sox consensus sites and enhances the vascular function of converted cells. Enforced expression of Sox17 increases expression of morphogenesis genes and promotes integration of transplanted converted cells into injured vessels. Thus, Ets transcription factors specify non-vascular, amniotic cells to EC-like cells, whereas Sox17 expression is required to confer EC function.
Suggested Citation
William Schachterle & Chaitanya R. Badwe & Brisa Palikuqi & Balvir Kunar & Michael Ginsberg & Raphael Lis & Masataka Yokoyama & Olivier Elemento & Joseph M. Scandura & Shahin Rafii, 2017.
"Sox17 drives functional engraftment of endothelium converted from non-vascular cells,"
Nature Communications, Nature, vol. 8(1), pages 1-12, April.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms13963
DOI: 10.1038/ncomms13963
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms13963. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.